Expression of the Alzheimer's disease mutations AβPP695sw and PSEN1M146I in double-transgenic Göttingen minipigs

Jannik E. Jakobsen, Marianne Gregers Johansen, Mette Schmidt, Ying Liu, Rong Li, Henrik Callesen, Margarita Melnikova, Mette Habekost, Carmela Matrone, Yvonne Bouter, Thomas A. Bayer, Anders Lade Nielsen, Monika Duthie, Paul E. Fraser, Ida Elisabeth Holm, Arne Lund Jørgensen

    Research output: Contribution to journalJournal articleResearchpeer-review

    35 Citations (Scopus)

    Abstract

    Mutations in the amyloid-β protein precursor gene (AβPP), the presenilin 1 gene (PSEN1) or the presenilin 2 gene (PSEN2) that increase production of the AβPP-derived peptide Aβ42 cause early-onset Alzheimer’s disease. Rodent models of the disease show that further increase in Aβ42 production and earlier brain pathology can be obtained by coexpressing AβPP and PSEN1 mutations. To generate such elevated Aβ42 level in a large animal model, we produced Göttingen minipigs carrying in their genome one copy of a human PSEN1 cDNA with the Met146Ile (PSEN1M146I) mutation and three copies of a human AβPP695 cDNA with the Lys670Asn/Met671Leu (AβPPsw) double-mutation. Both transgenes were expressed in fibroblasts and in the brain, and their respective proteins were processed normally. Immunohistochemical staining with Aβ42-specific antibodies detected intraneuronal accumulation of Aβ42 in brains from a 10- and an 18-month-old pig. Such accumulation may represent an early event in the pathogenesis of Alzheimer’s disease.
    Original languageEnglish
    JournalJournal of Alzheimer's Disease
    Volume53
    Issue number4
    Pages (from-to)1617-1630
    Number of pages14
    ISSN1387-2877
    DOIs
    Publication statusPublished - 2016

    Keywords

    • Alzheimer's disease
    • amyloid
    • porcine model
    • presenilin
    • transgenic

    Cite this